Last reviewed · How we verify
NCT05504629
Interindividual Postexercise Hypotension Response in Morbid Obesity
NA trial testing Concurrent training order 1 in Metabolic Syndrome in 40 participants. Completed in 5 October 2019.
5 September 2019
Quick facts
| Lead sponsor | Universidad Nacional Andres Bello |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 5 March 2019 |
| Primary completion | 5 September 2019 |
| Estimated completion | 5 October 2019 |
| Sites | 1 location across Chile |
Drugs / interventions tested
- Concurrent training order 1
- RT+ET
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Morbid Obesity — all drugs for Morbid Obesity →
Sponsor
Universidad Nacional Andres Bello
Who can join
Adults 18 to 59, any sex, with Metabolic Syndrome or Morbid Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A quasi-experimental study developed in sedentary morbidly obese men and women (age 43.6±11.3 y; body mass index \[BMI\] ≥40 kg/m2) were assigned to a CT group of ET plus RT (ET+RT; n=19; BMI 47.8±16.7) or RT plus ET order group (RT+ET; n=17; BMI 43.0±8.0). Subjects of both groups received eight exercise sessions over four weeks. Systolic (SBP), diastolic (DBP), mean arterial pressure \[MAP\], heart rate at rest \[HR\], and pulse pressure \[PP\] measurements before and after 10 minutes postexercise. Secondary outcomes were other anthropometric, body composition, metabolic, and physical condition parameters. Using the ∆SBP reduction, and quartile categorization (Q) in 'high' (Rs: quartile 4), 'moderate' (MRs: quartile 3), 'low' (LRs: quartile 2), and 'nonresponders' (NRs: quartile 1) were reported.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Characterizing the interindividual postexercise hypotension response for two order groups of concurrent training in patients with morbid obesity.
Álvarez C, Guede-Rojas F, Ramírez-Campillo R, Andrade DC, et al · · 2022 · cited 4× · PMID 36299263 · DOI 10.3389/fphys.2022.913645
Verify or expand the search:
- PubMed search for NCT05504629
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Universidad Nacional Andres Bello trials
Trials by the same sponsor.
- NCT06727500 — Effects of HIIT and Concurrent HITT/Plyometric Training on Muscle-tendon Structure, Function and Metabolism in Pediatric · NA · recruiting
- NCT06725901 — Pediatric Neurogenetic Diagnosis Support Platform · NA · recruiting
- NCT06428032 — Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy · NA · recruiting
- NCT06077123 — Telemonitoring Platforms and Chemotherapy-Associated Toxicity · NA · recruiting
- NCT06895850 — Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05504629 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Nacional Andres Bello
- Last refreshed: 24 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05504629.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing